Global Tardive Dyskinesia (TD) Treatment Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Tardive Dyskinesia (TD) Treatment Drugs
    1.2 Classification of Tardive Dyskinesia (TD) Treatment Drugs by Type
        1.2.1 Overview: Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type in 2020
        1.2.3 Valbenazine
        1.2.4 Deutetrabenazine
    1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market by Application
        1.3.1 Overview: Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size & Forecast
    1.5 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast by Region
        1.5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region, (2016-2021)
        1.5.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size and Prospect (2016-2026)
        1.5.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size and Prospect (2016-2026)
        1.5.6 South America Tardive Dyskinesia (TD) Treatment Drugs Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
        1.6.2 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints
        1.6.3 Tardive Dyskinesia (TD) Treatment Drugs Trends Analysis
2 Company Profiles
    2.1 Neurocrine Biosciences, Inc.
        2.1.1 Neurocrine Biosciences, Inc. Details
        2.1.2 Neurocrine Biosciences, Inc. Major Business
        2.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.1.4 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Neurocrine Biosciences, Inc. Recent Developments and Future Plans
    2.2 Teva Pharmaceutical Industries
        2.2.1 Teva Pharmaceutical Industries Details
        2.2.2 Teva Pharmaceutical Industries Major Business
        2.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.2.4 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
    2.3 Pfizer Inc.
        2.3.1 Pfizer Inc. Details
        2.3.2 Pfizer Inc. Major Business
        2.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.3.4 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Pfizer Inc. Recent Developments and Future Plans
    2.4 Biogen
        2.4.1 Biogen Details
        2.4.2 Biogen Major Business
        2.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.4.4 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Biogen Recent Developments and Future Plans
    2.5 Novartis AG
        2.5.1 Novartis AG Details
        2.5.2 Novartis AG Major Business
        2.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.5.4 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Novartis AG Recent Developments and Future Plans
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.6.4 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 AstraZeneca Recent Developments and Future Plans
    2.7 GlaxoSmithKline plc.
        2.7.1 GlaxoSmithKline plc. Details
        2.7.2 GlaxoSmithKline plc. Major Business
        2.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.7.4 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 GlaxoSmithKline plc. Recent Developments and Future Plans
    2.8 Bayer AG
        2.8.1 Bayer AG Details
        2.8.2 Bayer AG Major Business
        2.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.8.4 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Bayer AG Recent Developments and Future Plans
    2.9 Sanofi
        2.9.1 Sanofi Details
        2.9.2 Sanofi Major Business
        2.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product and Solutions
        2.9.4 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Tardive Dyskinesia (TD) Treatment Drugs Players Market Share
        3.2.2 Top 10 Tardive Dyskinesia (TD) Treatment Drugs Players Market Share
        3.2.3 Market Competition Trend
    3.3 Tardive Dyskinesia (TD) Treatment Drugs Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue and Market Share by Type (2016-2021)
    4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2016-2021)
    5.2 Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Type (2016-2026)
    6.2 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Application (2016-2026)
    6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        6.3.1 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country (2016-2026)
        6.3.2 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        6.3.3 Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        6.3.4 Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue by Type (2016-2026)
    7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue by Application (2016-2026)
    7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        7.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country (2016-2026)
        7.3.2 Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        7.3.3 France Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        7.3.5 Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        7.3.6 Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue by Type (2016-2026)
    8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue by Application (2016-2026)
    8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region
        8.3.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue by Region (2016-2026)
        8.3.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        8.3.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        8.3.4 South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        8.3.5 India Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        8.3.7 Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Type (2016-2026)
    9.2 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Application (2016-2026)
    9.3 South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        9.3.1 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country (2016-2026)
        9.3.2 Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        9.3.3 Argentina Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue by Type (2016-2026)
    10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue by Application (2016-2026)
    10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        10.3.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue by Country (2016-2026)
        10.3.2 Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
        10.3.4 UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer